# Ultrahypofractionated, Adaptive Radiation Therapy of Prostate Cancer

> **NCT06355050** · — · NOT_YET_RECRUITING · sponsor: **Jena University Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Prostate Cancer
- Adaptive Radiotherapy
- Quality of Life

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06355050
- **Lead sponsor:** Jena University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-15
- **Primary completion:** 2027-09-30
- **Final completion:** 2032-09-30
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-09-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06355050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06355050, "Ultrahypofractionated, Adaptive Radiation Therapy of Prostate Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06355050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*